* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Heart Failure 2013
Cardiovascular disease wikipedia , lookup
Remote ischemic conditioning wikipedia , lookup
Management of acute coronary syndrome wikipedia , lookup
Electrocardiography wikipedia , lookup
Lutembacher's syndrome wikipedia , lookup
Coronary artery disease wikipedia , lookup
Cardiac contractility modulation wikipedia , lookup
Jatene procedure wikipedia , lookup
Hypertrophic cardiomyopathy wikipedia , lookup
Mitral insufficiency wikipedia , lookup
Cardiac surgery wikipedia , lookup
Antihypertensive drug wikipedia , lookup
Heart failure wikipedia , lookup
Dextro-Transposition of the great arteries wikipedia , lookup
Arrhythmogenic right ventricular dysplasia wikipedia , lookup
Heart Failure 2013 Definition • Inability of the heart to supply blood to meet metabolic demands of tissues resulting in inadequate tissue perfusion and volume overload Heart Failure • Implies “biventricular failure” • Origin usually left sided • Left ventricle (LV)enlarges capacity, muscle size & shape = “ventricular remodeling” • LV weakens decreased ejection of blood, decreased stroke volume, decreased cardiac output Incidence 5 million cases 660,000 new cases/year Most common discharge diagnosis age >65 Causes of Heart Failure • • • • • • • • • Myocardial infarction Pulmonary embolism (RV failure) Cardiomyopathy (both RV & LV failure) Mitral insufficiency (LV failure) Aortic regurgitation/stenosis (LV failure) Hypertension (LV failure) Volume overload Myocarditis Infections/toxins Mechanism of Failure • Decline in cardiac function decreased cardiac output • Drop in cardiac output decreased ejection fraction • Ejection Fraction= percentage of blood left ventricle pumps out with each beat – Normal= 55-70% – <40% = impaired function Inciting Event Increased myocardial demand Ventricular Remodeling Sodium & water retention (Aldosterone) Decreased cardiac output Vasoconstriction (renin-angiotensisn) Neurohormonal Activation Sympathetic increase in heart rate & contractility Increased intravascular volume Increased wall stress and afterload Chronic Congestive Failure Compensatory Mechanisms Increased heart rate Heart Enlargement Vasoconstriction Increased afterload & cardiac workload Etiology • Cardiac Output dependent on: – Preload: amount of blood in left ventricle (LV) – Afterload: pressure against which LV must eject – Contractility: strength of contraction – Coordination of contraction between atria/ventricles – Heart Rate: amount of time available for filling and emptying ventricles Systolic Dysfunction “Poor Contraction” • Heart enlarges/does not contract normally • Decrease in muscle strength (thin walls) • Forward blood flow decreases systemic hypoperfusion • Stroke volume & ejection fraction decrease (EF<40%) • Pulmonary congestion Diastolic Dysfunction “Impaired Filling” • Inability of the ventricle to fully relax • Increased pressure & volume in ventricle • Pressures back up to pulmonary veins pulmonary congestion • Stroke volume reduced • Echo: normal EF?, left atrial enlargement, pulmonary hypertension, heart wall abnormalities, right ventricular dilation Clinical Manifestations • Left sided Failure (“Forward Failure”) – Blood backs into pulmonary veins & capillaries congestion • • • • • • • • • Dyspnea on exertion Paroxysmal nocturnal dyspnea Orthopnea Pulmonary edema Crackles Cough Tachycardia S3, S4, systolic murmur Insomnia, restlessness lung Clinical Manifestations • Right Sided Failure (“Backward Failure”) – Elevated pressures & congestion in systemic veins & capillaries • Peripheral/Dependent edema • Weight gain • Liver congestion • Distended neck veins • Abnormal fluid in body cavities – Pleural, abdominal • Anorexia & nausea • Nocturia • Weakness Assessment • • • • History of symptoms Limits of activity/response to rest Peripheral pulses: quality, character Inspect/palpate precordium for lateral displacement of point of maximum impulse • Sleeping patterns/sleep aids Diagnostic Evaluation EKG • Ventricular hypertrophy Echo • Ventricular hypertrophy • Chamber dilation • Abnormal wall motion CXR • Cardiomegaly • Pleural effusion • Vascular congestion Stages: American College of Cardiology/ American Heart Association Stage Definition Examples A High risk, no structural heart disease or HF HTN, CAD, diabetes, family hx cardiomyopathy B Structural heart disease, no signs of failure Prior MI, systolic dysfunction, valvular disease, RV hypertrophy C Structural heart disease, signs of failure Dyspnea, fatigue, exercise intolerance, orthopnea D Refractory HF despite maximal medical therapy Classification: New York Heart Association Class Functional Capacity I Patients with cardiac disease: no limitation on physical activity II Patients with cardiac disease: slight limitation on physical activity(fatigue, SOB, palpitation, anginal pain). Comfortable at rest III Marked limitation of physical activity (fatigue, SOB, palpitation, anginal pain). Comfortable at rest IV Inability to carry on any physical activity without discomfort. Symptoms of HF at rest Goal: improve ventricular dysfuncton & prevent progression Inotropes Reduce Afterload Reduce Preload Management • Inotropes – Improve contractility, stroke volume, ejection fraction, cardiac output – Increase myocardial oxygen consumption – Dobutamine, milrinone, digoxin • Biventricular pacing: cardiac resynchroniztion therapy (CRT). Synchronizes LV systolic function so that LV walls contract at same time Management • Reduction of Afterload – Decrease in resistance of blood, valves, blood vessels – Decreases work of left ventricle – Improved contractility, stroke volume, cardiac output • Angiotensin Converting Enzyme (ACE) inhibitors (captopril, enalapril) • Calcium Channel Blockers (nifedipine,verapamil) • Beta Blockers (metoprolol) • Angiotensin Receptor Blockers (ARBs) (valsartan, losartan) Management • Reduction of Preload – Diuretic therapy • Loop Diuretics: lasix, bumex • Thiazide Diuretics: hydrochlorothiazide • Potassium Sparing: spironolactone, triamterene – Venodilators (nitroglycerin) – Fluid & sodium restriction Interventions • Maintain adequate cardiac output • Physical/emotional rest • Evaluate for progression of left sided failure – Lowered systolic pressure – Narrowing of pulse pressure – Alterations in strong/weak pulsations – Auscultate heart sounds Interventions • Improve oxygentation – Raise head of bed – Auscultate lung fields – Observe for respiratory distress – Small frequent feedings – Oxygen as needed Interventions • Restore fluid balance – Diuretics – Strict I & o – Daily weight • Assess for weight fluctuations • *Include weight assessment in intershift report* – Observe for electrolyte depletion – Monitor for edema – Diet education Complications • • • • • • • Intractable/refractory heart failure Cardiac dysrhythmias Myocardial failure Digitalis toxicity Pulmonary infarction Pneumonia Emboli Core Measures • Evaluation of LV Function (EF) – Echo report – Cath report – Nuclear stress test Core Measures • Adult Smoking Cessation – Heart failure patient with a history of smoking within the past year • ACEI or ARB presecribed at discharge – Left Ventricular ejection fraction (LVEF) <40% Core Measure Exclusions • • • • • • • • • Patient refusal Patient on LVAD Patient <18 years of age Transfer to acute care hospital Comfort/Hospice care Discharged to hospice Expired Left AMA Patient involved in clinical trial Patient Education • Disease process: pumping action • Signs & symptoms of recurrence – Weight gain – Swelling of ankles, feet, abdomen – Cough – Fatigue – Frequent urination at night • Review medications, activity, diet Teach Back http://ruralhealth.uams.edu/healthliteracy/teachback References • Aherns, T., Prentice, D., & Kleinpell, R. (2011). Progressive care nursing certification. New York: McGraw Hill Medical. • Alspach, J. (2006). Core curriculum for critical care nursing. (6th ed., pp. 271-284). St Louis: Saunders Elsevier. • American Heart Associatin. (2005). Guideline update for the diagnosis and management of chronic heart failure in the adult. Circulation, 112, 154-235. • Aronow, W. (2006). Heart failure update. Geriatrics, 61(8), 16-20.